title: Mapping of c-Fos expression in the rat brain during the evolution of pentylenetetrazol-kindled seizures.
abstract: c-Fos protein immunocytochemistry was used to map the brain structures recruited during the evolution of seizures that follows repeated administration of a subconvulsive dose (35mg/kg, ip) of pentylenetetrazol in rats. c-Fos appeared earliest in nucleus accumbens shell, piriform cortex, prefrontal cortex, and striatum (stages 1 and 2 of kindling in comparison to control, saline-treated animals). At the third stage of kindling, central amygdala nuclei, entorhinal cortex, and lateral septal nuclei had enhanced concentrations of c-Fos. At the fourth stage of kindling, c-Fos expression was increased in basolateral amygdala and CA1 area of the hippocampus. Finally, c-Fos labeling was enhanced in the dentate gyrus of the hippocampus only when tonic-clonic convulsions were fully developed. The most potent changes in c-Fos were observed in dentate gyrus, piriform cortex, CA1, lateral septal nuclei, basolateral amygdala, central amygdala nuclei, and prefrontal cortex. Piriform cortex, entorhinal cortex, prefrontal cortex, lateral septal nuclei, and CA3 area of the hippocampus appeared to be the brain structures selectively involved in the process of chemically induced kindling of seizures.
authors.affiliation: Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland. jszyndler@yahoo.com
authors.forename: Janusz
authors.initials: J
authors.lastname: Szyndler
authors.forename: Piotr
authors.initials: P
authors.lastname: Maciejak
authors.forename: Danuta
authors.initials: D
authors.lastname: Turzyńska
authors.forename: Alicja
authors.initials: A
authors.lastname: Sobolewska
authors.forename: Ewa
authors.initials: E
authors.lastname: Taracha
authors.forename: Anna
authors.initials: A
authors.lastname: Skórzewska
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Lehner
authors.forename: Andrzej
authors.initials: A
authors.lastname: Bidziński
authors.forename: Adam
authors.initials: A
authors.lastname: Hamed
authors.forename: Aleksandra
authors.initials: A
authors.lastname: Wisłowska-Stanek
authors.forename: Paweł
authors.initials: P
authors.lastname: Krzaścik
authors.forename: Adam
authors.initials: A
authors.lastname: Płaźnik
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D001931:Brain Mapping; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000187:drug effects; D007696:Kindling, Neurologic / Q000187:drug effects*; D008297:Male; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010433:Pentylenetetrazole; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D051381:Rats; D012640:Seizures / Q000139:chemically induced* / Q000503:physiopathology*
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D010433:Pentylenetetrazole